The global lacrimal duct stent tube market is forecasted to grow by USD 7000.3 thousand during 2025-2030, accelerating at a CAGR of 3.2% during the forecast period. The report on the global lacrimal duct stent tube market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising geriatric population and nasolacrimal disorders, shift toward minimally invasive surgical procedures, technological advancements in stent materials.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope |
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 3.1% |
| CAGR | 3.2% |
| Incremental Value | $7000.3 thousand |
Technavio's global lacrimal duct stent tube market is segmented as below:
By Type
- Bicanalicular
- Monocanalicular
By Material
- Silicone
- Polyurethane and advanced polymers
- Metallic components
By End-User
- Hospitals
- Ophthalmic clinics
- Ambulatory surgical centers
Geography
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the expansion of outpatient surgical settings as one of the prime reasons driving the global lacrimal duct stent tube market growth during the next few years. Also, integration with advanced imaging modalities and favorable reimbursement policies and economics will lead to sizable demand in the market.
The report on the global lacrimal duct stent tube market covers the following areas:
- Global lacrimal duct stent tube market sizing
- Global lacrimal duct stent tube market forecast
- Global lacrimal duct stent tube market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global lacrimal duct stent tube market vendors that include Aurolab, BVI Holdings Ltd., Duckworth and Kent Ltd., E. Janach S.r.l., FCI Ophthalmics, Fuji Systems Co. Ltd., Geuder AG, Inami and Co. Ltd., Innovia Medical Inc., Jedmed, John Weiss and Son Ltd., Kaneka Corp., Labtician Ophthalmics Inc., Medtronic Plc, Network Medical Products Ltd, Novatech SA, Quest Medical Inc., RUMEX International Co., Stephens Instruments Inc., Surgitrac Instruments. Also, the global lacrimal duct stent tube market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Material
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Lacrimal Duct Stent Tube Market 2020 - 2024
- Historic Market Size - Data Table on Global Lacrimal Duct Stent Tube Market 2020 - 2024 ($ thousand)
- 5.2 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ thousand)
- 5.3 Material segment analysis 2020 - 2024
- Historic Market Size - Material Segment 2020 - 2024 ($ thousand)
- 5.4 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ thousand)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ thousand)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Lacrimal Duct Stent Tube Market
- 6.2 Impact of geopolitical conflicts on Global Lacrimal Duct Stent Tube Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Type
- 8.1 Market segments
- 8.2 Comparison by Type
- 8.3 Bicanalicular - Market size and forecast 2025-2030
- 8.4 Monocanalicular - Market size and forecast 2025-2030
- 8.5 Market opportunity by Type
- Market opportunity by Type ($ thousand)
9 Market Segmentation by Material
- 9.1 Market segments
- 9.2 Comparison by Material
- 9.3 Silicone - Market size and forecast 2025-2030
- 9.4 Polyurethane and advanced polymers - Market size and forecast 2025-2030
- 9.5 Metallic components - Market size and forecast 2025-2030
- 9.6 Market opportunity by Material
- Market opportunity by Material ($ thousand)
10 Market Segmentation by End-user
- 10.1 Market segments
- 10.2 Comparison by End-user
- 10.3 Hospitals - Market size and forecast 2025-2030
- 10.4 Ophthalmic clinics - Market size and forecast 2025-2030
- 10.5 Ambulatory surgical centers - Market size and forecast 2025-2030
- 10.6 Market opportunity by End-user
- Market opportunity by End-user ($ thousand)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 India - Market size and forecast 2025-2030
- 12.5.3 Japan - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Colombia - Market size and forecast 2025-2030
- 12.6.7 South Africa - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ thousand)
- Data Tables on Market opportunity by geography ($ thousand)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Rising geriatric population and nasolacrimal disorders
- Shift toward minimally invasive surgical procedures
- Technological advancements in stent materials
- 13.2 Market challenges
- Procedural complications and stent extrusion
- Reimbursement constraints and regulatory hurdles
- Supply chain disruptions and raw material scarcity
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Expansion of outpatient surgical settings
- Integration with advanced imaging modalities
- Favorable reimbursement policies and economics
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- 15.2 Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 BVI Holdings Ltd.
- BVI Holdings Ltd. - Overview
- BVI Holdings Ltd. - Product / Service
- BVI Holdings Ltd. - Key offerings
- SWOT
- 15.5 E. Janach S.r.l.
- E. Janach S.r.l. - Overview
- E. Janach S.r.l. - Product / Service
- E. Janach S.r.l. - Key offerings
- SWOT
- 15.6 Fuji Systems Co. Ltd.
- Fuji Systems Co. Ltd. - Overview
- Fuji Systems Co. Ltd. - Product / Service
- Fuji Systems Co. Ltd. - Key offerings
- SWOT
- 15.7 Geuder AG
- Geuder AG - Overview
- Geuder AG - Product / Service
- Geuder AG - Key offerings
- SWOT
- 15.8 Inami and Co. Ltd.
- Inami and Co. Ltd. - Overview
- Inami and Co. Ltd. - Product / Service
- Inami and Co. Ltd. - Key offerings
- SWOT
- 15.9 Innovia Medical Inc.
- Innovia Medical Inc. - Overview
- Innovia Medical Inc. - Product / Service
- Innovia Medical Inc. - Key offerings
- SWOT
- 15.10 John Weiss and Son Ltd.
- John Weiss and Son Ltd. - Overview
- John Weiss and Son Ltd. - Product / Service
- John Weiss and Son Ltd. - Key offerings
- SWOT
- 15.11 Kaneka Corp.
- Kaneka Corp. - Overview
- Kaneka Corp. - Business segments
- Kaneka Corp. - Key offerings
- Kaneka Corp. - Segment focus
- SWOT
- 15.12 Labtician Ophthalmics Inc.
- Labtician Ophthalmics Inc. - Overview
- Labtician Ophthalmics Inc. - Product / Service
- Labtician Ophthalmics Inc. - Key offerings
- SWOT
- 15.13 Medtronic Plc
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT
- 15.14 Network Medical Products Ltd
- Network Medical Products Ltd - Overview
- Network Medical Products Ltd - Product / Service
- Network Medical Products Ltd - Key offerings
- SWOT
- 15.15 Novatech SA
- Novatech SA - Overview
- Novatech SA - Product / Service
- Novatech SA - Key offerings
- SWOT
- 15.16 Quest Medical Inc.
- Quest Medical Inc. - Overview
- Quest Medical Inc. - Product / Service
- Quest Medical Inc. - Key offerings
- SWOT
- 15.17 RUMEX International Co.
- RUMEX International Co. - Overview
- RUMEX International Co. - Product / Service
- RUMEX International Co. - Key offerings
- SWOT
- 15.18 Surgitrac Instruments
- Surgitrac Instruments - Overview
- Surgitrac Instruments - Product / Service
- Surgitrac Instruments - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- 16.5 Data procurement
- 16.6 Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations